We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Emergency Medicine

Age-Adjusted D-Dimer Cutoffs Safely Rule Out Deep Vein Thrombosis: Results from the ADJUST-DVT Trial

MedXY Editorial Team•Jan 6, 2026•Emergency Medicine
Clinical DiagnosticsD-dimervenous thromboembolism

Highlights

The age-adjusted D-dimer cutoff (age × 10 µg/L for patients 50 years or older) has been prospectively validated to safely rule out deep vein thrombosis (DVT) in outpatients. In the multicenter ADJUST-DVT study, no symptomatic venous thromboembolic events were identified during a 3-month follow-up in patients ruled out using the adjusted threshold. This diagnostic strategy significantly increases the proportion of elderly patients in whom DVT can be ruled out without the need for leg compression ultrasonography, tripling the diagnostic yield in those aged 75 and older.

Introduction: The Diagnostic Dilemma of D-Dimer and Aging

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Combined Oral Contraception: Evolution, Safety, and Clinical ImplicationsThis review examines the development, efficacy, and safety of combined oral contraceptives (COCs), highlighting the emergence of natural-estrogen-containing formulations and their role in optimizing contraceptive care.Sep 7, 2026High Venous Thromboembolism Incidence in Endometrial Cancer Patients Undergoing Chemotherapy: Implications for Risk Stratification and ProphylaxisOver 25% of endometrial cancer patients receiving chemotherapy develop venous thromboembolism, with advanced cancer stage as the key risk factor, highlighting the need for tailored risk assessment and preventive strategies.Sep 1, 2026Oral Anticoagulation Significantly Lowers Venous Thromboembolism Rates in Ovarian Cancer Patients on First-Line Chemotherapy: Insights from a Quality Improvement ProjectA quality improvement initiative integrating oral anticoagulants reduced venous thromboembolism incidence in ovarian cancer patients undergoing first-line chemotherapy without increasing bleeding risks.Aug 25, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Endometriosis Linked to Elevated Long-Term Risk of Venous Thromboembolism: Insights from a Nationwide Danish Cohort Study
A comprehensive Danish nationwide study reveals that women with endometriosis face a significantly increased long-term risk of venous thromboembolism, underscoring the need for heightened clinical vigilance and tailored risk management.
Aug 22, 2026
Preventing Maternal Deaths from Venous Thromboembolism: Insights from a 12-Year Nationwide French AnalysisA nationwide French study reveals that nearly half of maternal deaths due to venous thromboembolism are preventable, emphasizing the importance of ongoing risk assessment and appropriate thromboprophylaxis during pregnancy and postpartum.Aug 19, 2026
Recurrent Venous Thromboembolism After Isolated Distal DVT: Insights from the RIDTS TrialThis article reviews the incidence and predictors of recurrent VTE following anticoagulation for isolated distal deep vein thrombosis, highlighting key risk factors and implications for treatment duration and patient management.Jul 7, 2026